Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L D Yee

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Transplantation|November 24, 1998
Comparative incidence of de novo nonlymphoid malignancies after liver transplantation under tacrolimus using surveillance epidemiologic end result dataA B Jain, L D Yee, M A Nalesnik, et al.
The American Journal of Pathology|July 1, 1990
Ovarian adenocarcinomas express fms-complementary transcripts and fms antigen, often with coexpression of CSF-1B M Kacinski, D Carter, K Mittal, et al.
Oncogene|June 1, 1991
FMS (CSF-1 receptor) and CSF-1 transcripts and protein are expressed by human breast carcinomas in vivo and in vitroB M Kacinski, K A Scata, D Carter, et al.
Nature Cell Biology|December 20, 2011
Reprogramming of the tumour microenvironment by stromal PTEN-regulated miR-320A Bronisz, J Godlewski, J A Wallace, et al.
Contemporary Clinical Trials|May 4, 2024
Making Informed Choices On Incorporating Chemoprevention into carE (MiCHOICE, SWOG 1904): Design and methods of a cluster randomized controlled trialK D Crew, G L Anderson, K B Arnold, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Transplantation|November 24, 1998
Comparative incidence of de novo nonlymphoid malignancies after liver transplantation under tacrolimus using surveillance epidemiologic end result dataA B Jain, L D Yee, M A Nalesnik, et al.
The American Journal of Pathology|July 1, 1990
Ovarian adenocarcinomas express fms-complementary transcripts and fms antigen, often with coexpression of CSF-1B M Kacinski, D Carter, K Mittal, et al.
Oncogene|June 1, 1991
FMS (CSF-1 receptor) and CSF-1 transcripts and protein are expressed by human breast carcinomas in vivo and in vitroB M Kacinski, K A Scata, D Carter, et al.
Nature Cell Biology|December 20, 2011
Reprogramming of the tumour microenvironment by stromal PTEN-regulated miR-320A Bronisz, J Godlewski, J A Wallace, et al.
Contemporary Clinical Trials|May 4, 2024
Making Informed Choices On Incorporating Chemoprevention into carE (MiCHOICE, SWOG 1904): Design and methods of a cluster randomized controlled trialK D Crew, G L Anderson, K B Arnold, et al.
Pageof 2